*risky investment opportunity - market capital ~$35 million*
“400 shares back in 2003 would have cost you $2million. Today they are yours for $1000.”
You read that correctly, no stock splits in all that time. Incredible. So why now should we be bullish?
The above monthly chart has a lot going on. Breaking it down:
1) Price action resistance breakout in May...
A bullish engulfing candlestick is present at a line of support. There's also a massive gap to fill. First price target is $0.1277.
Volume is also increasing, and RSI is in the oversold area. Low risk, high reward potential swing play.
Been seeing this one being tossed around for a short squeeze. i believe today's close will negate that opportunity unless some really good news comes out.
book a share is 6 so went with that and there eps growth. Will average down if get in my pullback range just don't want miss it if it doesn't. Added 1/3rd position
Potential gain:+400
Reward/Risk:+9
Timeframe: 9-12 months
I always try to present the charts in a simple comprehensive format to prevent any confusion.
This is just my technical view, neither a fundamental comment,nor a recommendation to trade..!
Please review my track record and calculate the odds for yourself..!
Don't forget to like, comment, and Follow to...
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics...
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics...
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics...
Hello,
Yes, what you are seeing is real from ATH to ATL. This could be a bargain but only if ThermoGenisis Holdings pulls a rabbit out of the hat. Apparently news of late may just be that. Read some of the highlights below then decide for yourself.
First Quarter and Subsequent Achievements:
*Net revenues for the first quarter of 2020 increased to $3.2...
Do Not Trade This! I'd personally wait for a retest around $6.90 before making my move. Might buy a few shares for fun tomorrow and see how it rolls.
For premium crypto & option signals, direct message me or @Kyer
DotcomJack | Easy Loot
